Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
CA 2420504 A1 · Owner: Di Angelantonio, Silvia · Inventors: Di Angelantonio, Silvia; Nistri, Andrea
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N-terminal 1-7 fragment of the CGRP peptide, possessing an enhancing action on the activation of neuronal nicotinic receptors, their pharmaceutical compositions containing the same and their use for the potential therapy of neurological diseases are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.